|

autologous hematopoietic stem cells added to planned CAR T Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1: 1

Top Sponsors

  • Joshua Sasine, MD, PhD1

Indications

  • Large B-cell Lymphoma1
  • Mantle Cell Lymphoma1
  • Hematologic Malignancy1
  • Acute Lymphoblastic Leukemia1
  • Diffuse Large B-Cell Lymphoma1

Los Angeles, California1 trial

Feasibility and Safety of Collecting and Combining Autologous Hematopoietic Stem Cells With Chimeric Antigen Receptor (CAR) T-Cell Therapy in Subjects With Relapsed/Refractory Hematological Malignancies

Cedars-Sinai Medical Center

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.